OTCFF (Ocumetics Technology) Return-on-Tangible-Equity: 0.00% (As of Mar. 2026)


OTCFF Ocumetics Technology Corp OTCFF
30 GF Score
Price $0.43
! 2 Warning Signs
View Full Analysis

What is Ocumetics Technology Return-on-Tangible-Equity?

Ocumetics Technology OTCFF 30 Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus rates OTCFF with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Ocumetics Technology ranks worse than 131925.99% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Ocumetics Technology's annualized net income for the quarter that ended in Mar. 2026 was $-11.07 Mil. Ocumetics Technology's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $-3.72 Mil. Therefore, Ocumetics Technology's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was N/A%.

The historical rank and industry rank for Ocumetics Technology's Return-on-Tangible-Equity or its related term are showing as below:

OTCFF's Return-on-Tangible-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.08
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Ocumetics Technology  (OTCPK:OTCFF) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Ocumetics Technology Return-on-Tangible-Equity Related Terms


Ocumetics Technology Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Ocumetics Technology's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocumetics Technology Return-on-Tangible-Equity Chart

Ocumetics Technology Annual Data
Trend Jul20 Jul21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Equity
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Ocumetics Technology Quarterly Data
Jul21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OTCFF vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison

For the Medical Instruments & Supplies subindustry, Ocumetics Technology's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocumetics Technology Return-on-Tangible-Equity vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ocumetics Technology's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Ocumetics Technology's Return-on-Tangible-Equity falls into.


OTCFF
30GF Score
Ocumetics Technology Corp OTCFF
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ocumetics Technology Return-on-Tangible-Equity Calculation

Ocumetics Technology's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-3.895/( (-1.796+-3.3 )/ 2 )
=-3.895/-2.548
=N/A %

Ocumetics Technology's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-11.072/( (-3.3+-4.131)/ 2 )
=-11.072/-3.7155
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
Ocumetics Technology (OTCFF) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Ocumetics Technology and its competitors. According to the industry distribution chart, Ocumetics Technology ranks #999999 out of 758 companies in the Medical Devices & Instruments industry.
Is Ocumetics Technology's Return-on-Tangible-Equity too high?
Ocumetics Technology's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Ocumetics Technology ranks #999999 out of 758 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ocumetics Technology has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Ocumetics Technology's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ocumetics Technology ranks #999999 out of 758 companies for Return-on-Tangible-Equity. This places Ocumetics Technology in the lower half of its industry. The industry median Return-on-Tangible-Equity is 4.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Ocumetics Technology and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ocumetics Technology's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocumetics Technology stock overvalued right now?
Ocumetics Technology (OTCFF) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. Ocumetics Technology's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Ocumetics Technology (OTCFF), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ocumetics Technology Business Description

Other Exchanges 2QB0:GermanyOTC:Canada
Address 639 - 5th Avenue SW, Suite 1250, Calgary, AB, CAN, T2P 0M9
Ocumetics Technology Corp is a Canadian research and product development company that specializes in adaptive lens designs. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses. The company is in the process of developing new lens technology, which is expected to link nerve impulses with the natural mechanisms for accommodation within the human eye.
30GF Score

Get the complete analysis for OTCFF

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.43
Price